The Europe non-alcoholic steatopatitis market is expected to reach US$ 6,765.21 million by 2028 from US$ 496.83 million in 2021. The market is estimated to grow at a CAGR of 45.2% from 2021 to 2028.
The Europe non-alcoholic steatopatitis market is expected to reach US$ 6,765.21 million by 2028 from US$ 496.83 million in 2021. The market is estimated to grow at a CAGR of 45.2% from 2021 to 2028.
Europe non-alcoholic steatopatitis market (NASH) Overview
Europe non-alcoholic steatopatitis market (NASH) remains an underdiagnosed condition, highlighting the need for increased awareness among both the general public and primary care physicians (PCPs). Early detection and structured referral pathways are crucial to identifying more patients and directing them to specialists for further evaluation.
To address this gap, the NASH Education Program launched a public awareness campaign on June 12, 2018, designated as International NASH Day, to educate people about non-alcoholic fatty liver disease (NAFLD) and its advanced form, NASH, which affects over 115 million individuals worldwide. Continuing these efforts, NASH 24X7, a digital platform dedicated to raising awareness about the NASH epidemic, expanded its initiatives on International NASH Day 2019 through healthcare professional (HCP) support, patient education, and media outreach via press releases and TV programs.
In India, the NASH Crusaders (part of NASH 24X7) collaborated with HCPs to conduct workshops on liver health, emphasizing the importance of a healthy lifestyle in preventing NAFLD/NASH. These campaigns utilized digital and print media to maximize public engagement.
Europe non-alcoholic steatopatitis market Growth and Segmentation
The Europe non-alcoholic steatopatitis market is projected to grow at a strong CAGR during the forecast period. The market is segmented by:
- Europe non-alcoholic steatopatitis market Product Type
- Vitamin E & Pioglitazone
- Ocaliva
- Elafibranor
- Selonsertib & Cenicriviroc (Fastest-growing segment)
- Others
- Europe non-alcoholic steatopatitis market Application
- Treatment (Dominant segment in 2020)
- Diagnosis
- Europe non-alcoholic steatopatitis market Sales Channel
- Hospital Pharmacy
- Online Provider
- Retail Pharmacy (Dominant segment in 2020)
- Europe non-alcoholic steatopatitis market Country
- Germany (Market leader in 2020)
- UK
- France
- Italy
- Spain
- Rest of Europe
Key Europe non-alcoholic steatopatitis market Players
Leading companies in the Europe NASH market include:
- Cadila Pharmaceuticals
- Intercept Pharmaceuticals
- Novartis AG
- Galmed Pharmaceuticals
- GENFIT
- ONE WAY LIVER SI
- BioPredictive S.A.S
- Siemens Healthineers AG
- Laboratory Corporation of America Holdings
These companies are focusing on organic growth strategies, such as product launches and expansions, to strengthen their market position. For instance, in November 2021, GENFIT announced that its NIS4 technology was recognized in a NIMBLE initiative study for its effectiveness in identifying “at-risk” NASH patients, further validating its diagnostic potential.
Conclusion
With rising awareness and advancements in treatment and diagnostics, the Europe NASH market is poised for significant growth. Increased public and physician education, along with strategic industry initiatives, will play a key role in improving early detection and patient outcomes.
Other Reports:
Europe Cosmeceuticals Market: https://business-news-insights.blogspot.com/2025/05/europe-cosmeceuticals-market-key.html
Europe Skin Care Products Market: https://sites.google.com/view/skin-care-products-market-e/home
Europe Graphene Market: https://penzu.com/p/5d7938edbf3bb185
Europe Methanol Market: https://github.com/SuryakantGadekar/Business-Market-Insights/issues/44
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
